A Study to Investigate Efficacy, Tolerability and Safety of ABY-035 in Patients With Active Psoriatic Arthritis
Clinical trial NCT04713072 · COMPLETED
Trial details
- NCT number
- NCT04713072
- Sponsor
- ACELYRIN Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-04
- Primary completion
- 2021-10-01
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.